Eco Fusion · raw details

Personalized Neuro-digital Therapeutics Platform · Herzliya · Founded 2014

inactive Mature ← back to profile

Highlights

1 patent

About

Personalized Neuro-digital Therapeutics Platform

Eco-Fusion is an AI-driven digital therapeutics company offering a flexible and patented closed-loop mobile platform to address a variety of chronic and mental conditions. Eco-Fusion partners with pharmaceutical, health, and insurance organizations to create digital therapeutics. The company's initial product is the award-winning Serenita, an AI-driven stress-reducing and focus-enhancing technology. Serenita has been shown to help patients with diabetes significantly reduce their blood sugar levels and lose significant weight. Eco-Fusion's broader online platform, NewMe, uses sensor data and patient-reported data to analyze and render personalized treatments through neuro-stimulation wearables and behavioral therapies.

Identity

NameEco Fusion
Slugeco-fusion
Type / kindstartup
Crunchbase IDeco-fusion
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgO7j_OMLDA

Status

Statusinactive
Status reasonNon Active, Dec 2022 ceased to operate
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityHerzliya
HQ addressHerzliya, Israel

Web & social

LinkedInhttps://www.linkedin.com/company/5048077
Facebookhttps://www.facebook.com/Serenita-626191547486705
YouTubehttps://www.youtube.com/channel/UC7zGcJC_kR-jyGwpMhSN1Tw?nohtml5=False

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesHealthcarePatientsProvidersFinancial ServicesFinancial ProductsInsurance
Business models
B2BB2B2CB2G
Tags
chronic-diseasewellnessnutritiondiabeteswearablecardiovascularobesitymhealthmobile-applicationspreventiondigital-healthcaretelehealthmedical-datadata-analyticsmedical-devicesmedical-technologieshealthcare-providersactionable-insightsartificial-intelligenceneuroscienceneuro-stimulationneurologynon-invasivepharmaceuticalsmonitoringreal-timechronic-patientspatientsinsurance-companiescardiologyadherenceremote-monitoringtelemedicinediagnosticstherapeuticsdigital-therapeuticstype-2-diabetesinfectious-diseaseminimally-invasivetreatmentsinsurtech

Funding

Total raised$1.4M
Current stageMature

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}